written by reader $2 covid pharma stock

By chuppy1130, June 4, 2020

Kyle Dennis touting a $2 pharma stock, heavy insider buying from CEO, upcoming FDA catalyst and heavily shorted.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

11 Comments
Inline Feedbacks
View all comments
jazzroxy
Irregular
jazzroxy
June 4, 2020 9:10 am

I have been barraged with emails, but have not been able to figure it out…

đź‘Ť 19
gkissi
Member
gkissi
June 5, 2020 9:56 am
Reply to  jazzroxy

I’m absolutely convinced this is OPK now! I got the following email from Kyle today:

…Like it or not
The country is going back to work.
Hospitals, universities, businesses, state governments…
We will all need more testing…both PCR and antibody
And that’s what my latest Sniper Report pick excels at…
In April it inked a deal with New York State to test state employees…

Now here’s the headline about that partnership with New York in April:
OPKO Health’s BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Dow Jones 4/29/20 1:35 PM ET

Add a Topic
3904
Add a Topic
6592
Add a Topic
4194
đź‘Ť 13
gkissi
Member
gkissi
June 4, 2020 11:40 am